Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.0 has been added. Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision: v3.4.3 is shown, replacing the previous v3.4.2. No study data or actionable details are altered.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedAdded Revision: v3.4.2; removed the government-funding downtime notice and the previous Revision: v3.4.1.SummaryDifference0.5%

- Check57 days agoChange DetectedA site-wide notice regarding potential updates due to funding and a new revision stamp (Revision: v3.4.1) were added, replacing the previous v3.4.0. These changes do not affect study data, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check64 days agoChange DetectedThe page now displays a glossary and shows new versioning details: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.3%

- Check78 days agoChange DetectedRevision text updated from v3.3.3 to v3.3.4 in the page header.SummaryDifference0.1%

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.